Works matching AU Brown, Michael P


Results: 67
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26683-0
    By:
    • El Khawanky, Nadia;
    • Hughes, Amy;
    • Yu, Wenbo;
    • Myburgh, Renier;
    • Matschulla, Tony;
    • Taromi, Sanaz;
    • Aumann, Konrad;
    • Clarson, Jade;
    • Vinnakota, Janaki Manoja;
    • Shoumariyeh, Khalid;
    • Miething, Cornelius;
    • Lopez, Angel F.;
    • Brown, Michael P.;
    • Duyster, Justus;
    • Hein, Lutz;
    • Manz, Markus G.;
    • Hughes, Timothy P.;
    • White, Deborah L.;
    • Yong, Agnes S. M.;
    • Zeiser, Robert
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers.

    Published in:
    Science Translational Medicine, 2021, v. 13, n. 612, p. 1, doi. 10.1126/scitranslmed.abd5524
    By:
    • Begley, C. Glenn;
    • Ashton, Mark;
    • Baell, Jonathan;
    • Bettess, Michael;
    • Brown, Michael P.;
    • Carter, Brett;
    • Charman, William N.;
    • Davis, Christopher;
    • Fisher, Simon;
    • Frazer, Ian;
    • Gautam, Anand;
    • Jennings, Michael P.;
    • Kearney, Philip;
    • Keeffe, Eloise;
    • Kelly, Darren;
    • Lopez, Angel F.;
    • McGuckin, Michael;
    • Parker, Michael W.;
    • Rayner, Craig;
    • Roberts, Brett
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    33

    Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study.

    Published in:
    PLoS ONE, 2024, v. 19, n. 11, p. 1, doi. 10.1371/journal.pone.0309778
    By:
    • Cohen, Graham;
    • Rapoport, Bernardo;
    • Chan, Sze W.;
    • Ruff, Paul;
    • Arance, Ana;
    • Mujika Eizmendi, Karmele;
    • Houghton, Baerin;
    • Brown, Michael P.;
    • Zielinski, Robert M.;
    • Muñoz Couselo, Eva;
    • Lyle, Megan;
    • Anderson, James R.;
    • Jain, Lokesh;
    • de Alwis, Dinesh;
    • Lala, Mallika;
    • Akala, Omobolaji;
    • Chartash, Elliot;
    • Jacobs, Conrad
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2018, v. 14, n. 1, p. 91, doi. 10.1111/ajco.12749
    By:
    • Takhar, Harminder;
    • Singhal, Nimit;
    • Mislang, Anna;
    • Kumar, Raj;
    • Kim, Laurence;
    • Selva‐Nayagam, Sid;
    • Pittman, Ken;
    • Karapetis, Chris;
    • Borg, Martin;
    • Olver, Ian N.;
    • Brown, Michael P.
    Publication type:
    Article
    47
    48
    49
    50